242 related articles for article (PubMed ID: 33031799)
1. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
2. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
3. 2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1
Abdel-Naim AB; Neamatallah T; Eid BG; Esmat A; Alamoudi AJ; Abd El-Aziz GS; Ashour OM
Oxid Med Cell Longev; 2018; 2018():4389484. PubMed ID: 30154949
[TBL] [Abstract][Full Text] [Related]
4. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
5. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
[TBL] [Abstract][Full Text] [Related]
6. PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats.
Mohamed MZ; Baky MAE; Hassan OA; Mohammed HH; Abdel-Aziz AM
Hum Exp Toxicol; 2020 Sep; 39(9):1224-1234. PubMed ID: 32228192
[TBL] [Abstract][Full Text] [Related]
7. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
8. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
9. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia.
Quintero-García M; Delgado-González E; Sánchez-Tusie A; Vázquez M; Aceves C; Anguiano B
Free Radic Biol Med; 2018 Feb; 115():298-308. PubMed ID: 29248723
[TBL] [Abstract][Full Text] [Related]
10. Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.
Bello II; Omigbodun A; Morhason-Bello I
BMC Urol; 2023 Dec; 23(1):207. PubMed ID: 38082261
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
[TBL] [Abstract][Full Text] [Related]
13. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
14. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
15. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ
Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617
[TBL] [Abstract][Full Text] [Related]
16. Protocatechuic acid ameliorates testosterone-induced benign prostatic hyperplasia through the regulation of inflammation and oxidative stress in castrated rats.
Akanni OO; Owumi SE; Olowofela OG; Adeyanju AA; Abiola OJ; Adaramoye OA
J Biochem Mol Toxicol; 2020 Aug; 34(8):e22502. PubMed ID: 32227675
[TBL] [Abstract][Full Text] [Related]
17. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats.
Shabani E; Kalantari H; Kalantar M; Goudarzi M; Mansouri E; Kalantar H
BMC Complement Med Ther; 2021 Dec; 21(1):301. PubMed ID: 34930229
[TBL] [Abstract][Full Text] [Related]
18. The effect of pomegranate fruit extract on testosterone-induced BPH in rats.
Ammar AE; Esmat A; Hassona MD; Tadros MG; Abdel-Naim AB; Guns ES
Prostate; 2015 May; 75(7):679-92. PubMed ID: 25620586
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin attenuates testosterone-induced benign prostatic hyperplasia in rats: role of peroxisome proliferator-activated receptor-γ and cyclo-oxygenase-2.
Ishola IO; Tijani HK; Dosumu OO; Anunobi CC; Oshodi TO
Fundam Clin Pharmacol; 2017 Dec; 31(6):652-662. PubMed ID: 28636803
[TBL] [Abstract][Full Text] [Related]
20. Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet.
Li Y; Shi B; Dong F; Zhu X; Liu B; Liu Y
Aging (Albany NY); 2019 Aug; 11(15):5570-5578. PubMed ID: 31412319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
